Propylthiourethan | 55365-87-2

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫代羰基化合物
• 英文名称: Propylthiourethan
• 英文别名: N-propyl-O-ethylthiocarbamate；EtOC(S)NHPr；propyl-thiocarbamic acid O-ethyl ester；Propylthiocarbamic acid O-ethyl ester；O-ethyl N-propylcarbamothioate
• CAS: 55365-87-2
• 化学式: C₆H₁₃NOS
• mdl: MFCD18972361
• 分子量: 147.241
• InChiKey: GHYOYKNBJJMRDO-UHFFFAOYSA-N

物化性质

• 沸点：
  110.5°C (estimate)
• 密度：
  1.017 (estimate)

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  9
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.833
• 拓扑面积：
  53.4
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  Propylthiourethan 以90%的产率得到
  参考文献：
  名称：

  HANEFELD W., J. LIEBIGS ANN. CHEM. , 1974, NO 12, 2015-2018

  摘要：

  DOI：
• 作为产物：
  描述：

  乙醇 、 异氰酸丙酯 生成 Propylthiourethan
  参考文献：
  名称：

  Hanefeld, Justus Liebigs Annalen der Chemie, 1974, vol. No. 12, p. 2015 - 2018

  摘要：

  DOI：

文献信息

• [EN] IMIDAZOISOQUINOLINE COMPOUNDS, COMPOSITIONS COMPRISING THE COMPOUNDS AND THEIR USE FOR CONTROLLING INVERTEBRATE PESTS<br/>[FR] COMPOSÉS IMIDAZOISOQUINOLÉINE, COMPOSITIONS COMPRENANT LES COMPOSÉS ET LEUR UTILISATION POUR LUTTER CONTRE DES ORGANISMES NUISIBLES INVERTÉBRÉS
  申请人：BASF SE

  公开号：WO2016113271A1

  公开（公告）日：2016-07-21

  The present invention relates to novel imidazoisoquinoline compounds of the formula I and the N-oxides, stereoisomers, tautomers and agriculturally or veterinarily acceptable salts thereof wherein A1 is N or C(R2), A2 is N or C(R3); A3 is N or C(R4); A4 is N or C(R5); A5 is N or C(R6); and where Ar, R, R1, R2, R3, R4,R5 and R6 are as defined in the claims. The compounds of formula (I), as well as the N-oxides, stereoisomers, tautomers and agriculturally or veterinarily acceptable salts thereof, are useful for combating or controlling invertebrate pests, in particular arthropod pests and nematodes. The invention also relates to a method for controlling invertebrate pests by using these compounds and to plant propagation material and to an agricultural and a veterinary composition comprising said compounds.

  本发明涉及具有以下结构的新型咪唑异喹啉化合物及其N-氧化物、立体异构体、互变异构体和农业或兽医可接受的盐：其中A1为N或C(R2)，A2为N或C(R3)；A3为N或C(R4)；A4为N或C(R5)；A5为N或C(R6)；Ar、R、R1、R2、R3、R4、R5和R6的定义如索赔中所述。式(I)的化合物及其N-氧化物、立体异构体、互变异构体和农业或兽医可接受的盐，可用于对抗或控制无脊椎动物害虫，特别是节肢动物害虫和线虫。该发明还涉及一种利用这些化合物控制无脊椎动物害虫的方法，以及包含所述化合物的植物繁殖材料和农业和兽医组合物。
• A synthesis of N-alkyl and N,N-dialkyl O-ethyl thiocarbamates from diethyl dixanthogenate using different oxidants
  作者：Milutin M. Milosavljević、Milica Sovrlić、Aleksandar D. Marinković、Dragan D. Milenković

  DOI：10.1007/s00706-010-0328-y

  日期：2010.7

  yield was studied. The results obtained by use of these three methods were compared with those obtained by reaction of sodium ethyl xanthogenacetate and amines, and of sodium ethyl xanthate with amines in the presence of sulfated nickel zeolite catalyst. The reaction mechanism of sodium hypochlorite oxidation has been established on the basis of isolation of reaction intermediates and determination of

  摘要N-烷基和N，N-二烷基O的新颖合成已经在实验室规模上开发了使用三个氧化系统的二黄原酸二乙酯和伯胺和仲胺生成的乙基硫代氨基甲酸酯，并且已在半工业规模应用了使用次氯酸钠的方法。研究了氧化剂，次氯酸钠，原位生成的过氧乙酸和乙酸锰（II）/氧气体系对产品纯度和收率的影响。将通过这三种方法获得的结果与在硫酸化镍沸石催化剂存在下乙基黄原酸乙酸钠和胺以及乙基黄原酸钠和胺反应得到的结果进行比较。在分离反应中间体并通过傅立叶变换红外光谱测定其结构的基础上，建立了次氯酸钠氧化的反应机理。1 H和13 C NMR以及质谱法。与商业和催化促进的合成方法相比，建议的次氯酸钠和乙酸锰（II）体系具有许多优势，因为它们是新型的生态友好型合成方法。 图形概要
• 1:3 Platinum(II) halide complexes with thiocarbamic esters. The crystal and molecular structure of chloro-tris(N-propyl-O-ethylthiocarbamate)platinum(II) chloride
  作者：R. Bardi、A.M. Piazzesi、A. Del Pra、M. Celeste、G. Faraglia、L. Trincia

  DOI：10.1016/s0020-1693(00)89072-6

  日期：1985.8

  spectroscopy. The structure of [Pt(PTC)3Cl]Cl} was determined from three-dimensional X-ray diffractometer data. The complex crystallized in the triclinic system, space group P with two molecules in a unit cell of dimensions: a = 16.935(4), b = 10.697(3), c = 8.949(3) », a = 114.1(1), β = 83.4(1), γ = 98.4(1)°. Full-matrix least-squares refinement converged at R = 0.056 (Rw = 0.061). The structure consist of

  制备了配合物[PTL 3 X] X}，其中L ＝ N-乙基O-乙基硫代氨基甲酸酯（ETC），N-丙基O-乙基硫代氨基甲酸酯（PTC）和X ＝ Cl，Br，并通过红外光谱表征。[PT（PTC）3 Cl] Cl}的结构由三维X射线衍射仪数据确定。该复合物在三斜晶系系统中结晶，空间群P在一个晶胞中具有两个分子，其尺寸为：a = 16.935（4），b = 10.697（3），c = 8.949（3）»，a = 114.1（1）， β= 83.4（1），γ= 98.4（1）°。全矩阵最小二乘优化收敛于R = 0.056（R w= 0.061）。结构由分离的分子，每个含有[PT（PTC）3 CL] +阳离子，其保持氯-通过三个PTC分子的NH基团的阴离子通过氢键。
• NOVEL ANTIMICROBIALS
  申请人：Jain Rajesh

  公开号：US20110245258A1

  公开（公告）日：2011-10-06

  The present invention relates to novel phenyl oxazolidinone compounds of formula I, their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of formula I or their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of formula I and methods of using them. The compounds of the present invention are useful as antimicrobial agents, effective against a number of aerobic and/or anaerobic Gram positive and/or Gram negative pathogens such as multi drug resistant species of Staphylococcus, Streptococcus, Enterococcus, Bacterioides, Clostridia, H. influenza, Moraxella, acid-fast organisms such as Mycobacterium tuberculosis as well as Linezolid resistant species of Staphylococcus and Enterococcus.

  本发明涉及公式I的新型苯基噁唑啉酮化合物，它们的药学上可接受的类似物、互变异构体、立体异构体、多晶形态、前药、代谢物、盐或其溶剂。本发明还涉及合成公式I的新化合物或其药学上可接受的类似物、互变异构体、立体异构体、多晶形态、前药、代谢物、盐或其溶剂的过程。本发明还提供了包含公式I的新化合物的制药组合物和使用它们的方法。本发明的化合物是抗微生物剂，对多种需氧和/或厌氧革兰阳性和/或革兰阴性病原体具有有效作用，如金黄色葡萄球菌、链球菌、肠球菌、拟杆菌、梭菌、流感嗜血杆菌、摩拉克斯氏菌、抗利多霉素的金黄色葡萄球菌和肠球菌等耐药菌。
• JPH05139901A
  申请人：——

  公开号：JPH05139901A

  公开（公告）日：1993-06-08